Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer NCT03181035 Tongue Cancer
(18)F-Fluoroazo...
Pimonidazole
18 Years - Sunnybrook Health Sciences Centre View Radiotherapy of Tongue Cancer Using an Intraoral Stent NCT04337853 Tongue Cancer
Intraoral stent
No intraoral st...
18 Years - Oslo University Hospital View Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer NCT02177838 Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey View Ultrasound in Tongue Cancer- a Help to Decide Depth of Invasion and to Improve the Surgical Margin NCT04059861 Tongue Cancer
Floor of Mouth ...
Ultrasound
18 Years - Region Örebro County View Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia NCT04534127 Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Radiation: Diff...
18 Years - Alpha Tau Medical LTD. View Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00507767 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care NCT01816841 Lip and Oral Ca...
Oral Cavity Ver...
Stage 0 Lip and...
Tongue Cancer
fluorescence im...
biopsy
examination
Comparison of s...
18 Years - Ohio State University Comprehensive Cancer Center View Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer NCT00963326 Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI) View S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00096512 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
sorafenib tosyl...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Retreatment With Intratumoral Diffusing Alpha Radiation Emitters NCT04540588 Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Radiation: Diff...
18 Years - Alpha Tau Medical LTD. View Surgical Margin Assessment by 3D Ultrasound NCT05740774 Tongue Cancer
Squamous Cell C...
Head and Neck C...
3D ultrasound
18 Years - Rigshospitalet, Denmark View Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene NCT03602079 HER2-positive B...
HER2 Gene Mutat...
HER-2 Gene Ampl...
HER2 Positive G...
Salivary Gland ...
Salivary Gland ...
Salivary Gland ...
Salivary Gland ...
Lung Cancer
Colo-rectal Can...
Rare Diseases
Solid Tumor
Recurrent Gastr...
Recurrent Colon...
Recurrent Breas...
Head and Neck C...
Head and Neck C...
Bladder Cancer
Cervical Cancer
Liver Cancer
Bile Duct Cance...
Urologic Cancer
Pancreatic Canc...
Prostate Cancer
Recurrent Prost...
Rectal Cancer
Recurrent Ovari...
Recurrent Renal...
Rectal Cancer S...
Rectal Cancer S...
Rectal Cancer S...
Skin Cancer
Mouth Cancer
Lip Cancer Stag...
Tongue Cancer
Breast Neoplasm...
Larynx Cancer
Tonsil Cancer
Palate Cancer
Mucoepidermoid ...
Primary Periton...
Mucinous Adenoc...
Mucinous Breast...
Cholangiocarcin...
A166
18 Years - Klus Pharma Inc. View Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S NCT04430842 Astrocytoma
Brain Cancer
Brain Metastase...
Bladder Cancer
Breast Cancer
Cervical Cancer
Cholangiocarcin...
Colorectal Canc...
Esophagus Cance...
Gastric Cancer
Head and Neck C...
Kidney Cancer
Liver Cancer
Lung Cancer
Melanoma
Ovarian Cancer
Pancreatic Canc...
Pleural Mesothe...
Prostate Cancer
Sarcoma
Tongue Cancer
Thymic Carcinom...
Urinary Tract C...
QBS10072S
18 Years - Quadriga Biosciences, Inc. View Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases NCT00062348 Colorectal Canc...
Head and Neck C...
Metastatic Canc...
boronophenylala...
sodium borocapt...
conventional su...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC View Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer NCT00963326 Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI) View Surgical Margin Assessment by 3D Ultrasound NCT05740774 Tongue Cancer
Squamous Cell C...
Head and Neck C...
3D ultrasound
18 Years - Rigshospitalet, Denmark View Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure NCT00530049 Head and Neck C...
Psychosocial Ef...
questionnaire a...
assessment of t...
psychosocial as...
quality-of-life...
18 Years - Memorial Sloan Kettering Cancer Center View Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck NCT02035527 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
sorafenib tosyl...
cisplatin
docetaxel
Correlative Stu...
18 Years - Ohio State University Comprehensive Cancer Center View High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer NCT03008330 Tongue Cancer
High-activity n...
30 Years - 60 Years Fuda Cancer Hospital, Guangzhou View Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer NCT00899704 Head and Neck C...
microarray anal...
allele-specific...
diagnostic labo...
- Alliance for Clinical Trials in Oncology View Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer NCT01953952 Stage III Squam...
Stage IVA Squam...
Tongue Cancer
therapeutic con...
intensity-modul...
cisplatin
quality-of-life...
laboratory biom...
18 Years - Radiation Therapy Oncology Group View Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer NCT00851877 Head and Neck C...
Cetuximab
Cisplatin
Nab-Paclitaxel
intensity-modul...
18 Years - 120 Years University of Texas Southwestern Medical Center View Oral Stent Device for Radiation Treatments of Oral Cancers NCT04041141 Tongue Tumor
Tongue Cancer
CT Scan
Experimental Or...
18 Years - Indiana University View Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy NCT01728480 Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
entolimod
intensity-modul...
cisplatin
pharmacological...
laboratory biom...
18 Years - Roswell Park Cancer Institute View Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer NCT00833261 Head and Neck C...
cetuximab
cisplatin
intensity-modul...
Nab-Paclitaxel
18 Years - 120 Years University of Texas Southwestern Medical Center View Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00507767 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer NCT02177838 Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey View Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer NCT01718223 Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Tongue Cancer
photodynamic th...
therapeutic con...
laboratory biom...
temoporfin
18 Years - Roswell Park Cancer Institute View Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy NCT02123511 Mucositis
Oral Complicati...
Recurrent Adeno...
Recurrent Basal...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Lympho...
Stage II Lympho...
Stage II Mucoep...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Basal...
Stage III Lymph...
Stage III Lymph...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Lympho...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Lymph...
Stage IVA Mucoe...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Lymph...
Stage IVB Mucoe...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Lymph...
Stage IVC Mucoe...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
acetylcysteine
placebo
quality-of-life...
questionnaire a...
18 Years - Mayo Clinic View Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers NCT00900419 Esophageal Canc...
Head and Neck C...
Lung Cancer
Precancerous Co...
immunohistochem...
laboratory biom...
sputum cytology
biopsy
21 Years - 90 Years University of Colorado, Denver View Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer NCT01084083 Head and Neck C...
Precancerous Co...
cetuximab
intensity-modul...
Paclitaxel
Cisplatin
18 Years - Eastern Cooperative Oncology Group View Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy NCT01156142 Head and Neck C...
Mucositis
Oral Complicati...
Pain
doxepin hydroch...
placebo
18 Years - Alliance for Clinical Trials in Oncology View Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer NCT00656513 Head and Neck C...
Xerostomia
Pilocarpine
ALTENS
18 Years - Radiation Therapy Oncology Group View Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors NCT01504932 Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Tongue Cancer
BRB Lozenge
Survey Administ...
Laboratory Biom...
pharmacological...
21 Years - Ohio State University Comprehensive Cancer Center View Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer NCT01313390 Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London View Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. NCT03889899 Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Radiation: Diff...
18 Years - Alpha Tau Medical LTD. View Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer NCT00665392 Head and Neck C...
cisplatin
docetaxel
fluorouracil
Cetuximab
18 Years - 75 Years GERCOR - Multidisciplinary Oncology Cooperative Group View GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer NCT00293462 Head and Neck C...
Mucositis Oral
Radiation Toxic...
Tongue Cancer
sargramostim
oral salt and s...
18 Years - University of California, San Francisco View Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia NCT00330382 Lip and Oral Ca...
Oral Leukoplaki...
Oropharyngeal C...
Tongue Cancer
Bowman-Birk inh...
placebo
laboratory biom...
18 Years - National Cancer Institute (NCI) View Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. NCT01469429 Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center View Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer NCT00114283 Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
lapatinib ditos...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer NCT00049283 Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) NCT03886181 Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Device: Radiati...
18 Years - Alpha Tau Medical LTD. View Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract NCT00765440 Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 Years Centre Antoine Lacassagne View Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer NCT00049283 Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab NCT00939627 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
cetuximab
placebo
sorafenib tosyl...
laboratory biom...
quality-of-life...
18 Years - National Cancer Institute (NCI) View Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia NCT00101335 Head and Neck C...
Precancerous Co...
celecoxib
18 Years - Fox Chase Cancer Center View Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer NCT02245100 Metastatic Squa...
Salivary Gland ...
Stage IIIA Non-...
Stage IIIB Non-...
Stage IV Non-sm...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
Cytology specim...
Laboratory biom...
18 Years - Thomas Jefferson University View Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy NCT01210872 Head and Neck C...
questionnaire a...
quality-of-life...
standard follow...
18 Years - 70 Years National Cancer Institute (NCI) View High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer NCT03008330 Tongue Cancer
High-activity n...
30 Years - 60 Years Fuda Cancer Hospital, Guangzhou View Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck NCT00906360 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Untreated Metas...
sunitinib malat...
pharmacological...
3-dimensional c...
cetuximab
18 Years - National Cancer Institute (NCI) View GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer NCT00293462 Head and Neck C...
Mucositis Oral
Radiation Toxic...
Tongue Cancer
sargramostim
oral salt and s...
18 Years - University of California, San Francisco View Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer NCT00397384 Adenocarcinoma ...
Adenocarcinoma ...
Advanced Adult ...
Carcinoma of th...
Gastrointestina...
Metastatic Gast...
Metastatic Squa...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Colon...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Pancr...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Colon ...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Unresectable Ex...
Unresectable Ga...
cetuximab
erlotinib hydro...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal Cancer NCT01949740 Stage I Squamou...
Stage II Squamo...
Stage III Squam...
Stage IVA Squam...
Tongue Cancer
questionnaire a...
quality-of-life...
18 Years - University of Chicago View Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal Cancer NCT01949740 Stage I Squamou...
Stage II Squamo...
Stage III Squam...
Stage IVA Squam...
Tongue Cancer
questionnaire a...
quality-of-life...
18 Years - University of Chicago View Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue NCT02584270 Tongue Neoplasm...
Tongue Cancer
Oral Cancer
Palatal Augment...
Articulation Th...
18 Years - University of Michigan View Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer NCT02849379 Recurrent Tongu...
Cryosurgery
NK immunotherap...
30 Years - 70 Years Fuda Cancer Hospital, Guangzhou View Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer NCT00068497 Anaplastic Thyr...
Insular Thyroid...
Metastatic Para...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Parat...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Thyro...
Recurrent Verru...
Stage III Folli...
Stage III Papil...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IIIB Non-...
Stage IV Lympho...
Stage IV Non-sm...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Esthe...
Stage IVA Folli...
Stage IVA Inver...
Stage IVA Lymph...
Stage IVA Midli...
Stage IVA Mucoe...
Stage IVA Papil...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Esthe...
Stage IVB Folli...
Stage IVB Inver...
Stage IVB Lymph...
Stage IVB Midli...
Stage IVB Mucoe...
Stage IVB Papil...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Esthe...
Stage IVC Folli...
Stage IVC Inver...
Stage IVC Lymph...
Stage IVC Midli...
Stage IVC Mucoe...
Stage IVC Papil...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Thryoid Gland N...
Thyroid Gland M...
Tongue Cancer
Untreated Metas...
gefitinib
- National Cancer Institute (NCI) View Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy NCT01728480 Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
entolimod
intensity-modul...
cisplatin
pharmacological...
laboratory biom...
18 Years - Roswell Park Cancer Institute View Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract NCT00765440 Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 Years Centre Antoine Lacassagne View Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00423930 Head and Neck C...
bevacizumab
cisplatin
conventional su...
intensity-modul...
18 Years - Memorial Sloan Kettering Cancer Center View Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer NCT01313390 Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London View Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity NCT02295540 Stage III Squam...
Stage III Verru...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
hypofractionate...
intensity-modul...
therapeutic con...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey View Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer NCT00875849 Head and Neck C...
cetuximab
cisplatin
radiation thera...
18 Years - Centre Antoine Lacassagne View Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00423930 Head and Neck C...
bevacizumab
cisplatin
conventional su...
intensity-modul...
18 Years - Memorial Sloan Kettering Cancer Center View Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma NCT01195922 Mouth Neoplasms
Head and Neck N...
Tongue Neoplasm...
Carcinoma, Squa...
Sirolimus
18 Years - 80 Years National Institutes of Health Clinical Center (CC) View Phase II Trial of Allovectin-7® for Head and Neck Cancer NCT00050388 Head and Neck C...
Squamous Cell C...
Head and Neck N...
Carcinoma of th...
Allovectin-7®
18 Years - Vical View Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00507767 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) NCT03886181 Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Device: Radiati...
18 Years - Alpha Tau Medical LTD. View Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia NCT00101335 Head and Neck C...
Precancerous Co...
celecoxib
18 Years - Fox Chase Cancer Center View Vaccine Therapy in Treating Patients With Head and Neck Cancer NCT00404339 Head and Neck C...
mutant p53 pept...
tetanus toxoid ...
adjuvant therap...
18 Years - 120 Years University of Pittsburgh View Quality of Life in Patients Treated for Tongue and/or Jaw Neoplasia Before and After Speech Therapy NCT04126226 Tongue Cancer
Jaw Cancer
Oral Cancer
Intelligibility...
Speech-language...
Speech therapy ...
Speech therapy ...
18 Years - Hospital de Clinicas de Porto Alegre View Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck NCT00033618 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
ixabepilone
laboratory biom...
18 Years - National Cancer Institute (NCI) View Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. NCT01469429 Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center View 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy NCT01806675 Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Male Breast Can...
Metastatic Squa...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Colon...
Recurrent Esthe...
Recurrent Hypop...
Recurrent Inver...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Nasop...
Recurrent Non-s...
Recurrent Oroph...
Recurrent Pancr...
Recurrent Paran...
Recurrent Recta...
Recurrent Renal...
Recurrent Saliv...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Non-sm...
Stage IV Pancre...
Stage IV Renal ...
Stage IVA Colon...
Stage IVA Recta...
Stage IVA Saliv...
Stage IVB Colon...
Stage IVB Saliv...
Stage IVC Saliv...
Tongue Cancer
Unspecified Adu...
18F-fludeoxyglu...
18F-FPPRGD2
18 Years - Stanford University View Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer NCT01316757 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Untreated Metas...
cetuximab
paclitaxel
carboplatin
erlotinib hydro...
laboratory biom...
18 Years - Fox Chase Cancer Center View Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery NCT01333085 Head and Neck C...
carboplatin
RAD001
paclitaxel
18 Years - GERCOR - Multidisciplinary Oncology Cooperative Group View Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) NCT03737734 Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Radiation: Diff...
18 Years - Alpha Tau Medical LTD. View RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer NCT00956007 Head and Neck C...
cetuximab
intensity-modul...
18 Years - Radiation Therapy Oncology Group View Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure NCT00530049 Head and Neck C...
Psychosocial Ef...
questionnaire a...
assessment of t...
psychosocial as...
quality-of-life...
18 Years - Memorial Sloan Kettering Cancer Center View